AAAAAA

   
Results: 1-10 |
Results: 10
Blockade of the metabotropic glutamate receptor subtype 5 (mGluR5) produces antiparkinsonian-like effects in rats
Authors: Ossowska, K Konieczny, J Wolfarth, S Wieronska, J Pilc, A
Citation: K. Ossowska et al., Blockade of the metabotropic glutamate receptor subtype 5 (mGluR5) produces antiparkinsonian-like effects in rats, NEUROPHARM, 41(4), 2001, pp. 413-420
Decline in motor functions in aging is related to the loss of NMDA receptors
Authors: Ossowska, K Wolfarth, S Schulze, G Wardas, J Pietraszek, M Lorenc-Koci, E Smialowska, M Coper, H
Citation: K. Ossowska et al., Decline in motor functions in aging is related to the loss of NMDA receptors, BRAIN RES, 907(1-2), 2001, pp. 71-83
(S)-4C3HPG, a mixed group I mGlu receptor antagonist and a group II agonist, administered intrastriatally, counteracts parkinsonian-like muscle rigidity in rats
Authors: Lorenc-Koci, E Wardas, J Wolfarth, S Pilc, A
Citation: E. Lorenc-koci et al., (S)-4C3HPG, a mixed group I mGlu receptor antagonist and a group II agonist, administered intrastriatally, counteracts parkinsonian-like muscle rigidity in rats, BRAIN RES, 903(1-2), 2001, pp. 177-184
Metabotropic glutamate receptors - different therapeutic perspectives
Authors: Wolfarth, S
Citation: S. Wolfarth, Metabotropic glutamate receptors - different therapeutic perspectives, AMINO ACIDS, 19(1), 2000, pp. 79-80
The role of glutamate receptors in antipsychotic drug action
Authors: Ossowska, K Pietraszek, M Wardas, J Nowak, G Zajaczkowski, W Wolfarth, S Pilc, A
Citation: K. Ossowska et al., The role of glutamate receptors in antipsychotic drug action, AMINO ACIDS, 19(1), 2000, pp. 87-94
The role of metabotropic glutamate receptor (mGluR) ligands in parkinsonian muscle rigidity
Authors: Wolfarth, S Konieczny, J Lorenc-Koci, E Ossowska, K Pilc, A
Citation: S. Wolfarth et al., The role of metabotropic glutamate receptor (mGluR) ligands in parkinsonian muscle rigidity, AMINO ACIDS, 19(1), 2000, pp. 95-101
Effect of acute and chronic administration of 1,2,3,4-tetrahydroisoquinoline on muscle tone, metabolism of dopamine pn the striatum and tyrosine hydroxylase immunocytochemistry in the substantia nigra, in rats
Authors: Lorenc-Koci, E Smialowska, M Antkiewicz-Michaluk, L Golembiowska, K Bajkowska, M Wolfarth, S
Citation: E. Lorenc-koci et al., Effect of acute and chronic administration of 1,2,3,4-tetrahydroisoquinoline on muscle tone, metabolism of dopamine pn the striatum and tyrosine hydroxylase immunocytochemistry in the substantia nigra, in rats, NEUROSCIENC, 95(4), 2000, pp. 1049-1059
L-701,324, a selective antagonist at the glycine site of the NMDA receptor, counteracts haloperidol-induced muscle rigidity in rats
Authors: Konieczny, J Ossowska, K Schulze, G Coper, H Wolfarth, S
Citation: J. Konieczny et al., L-701,324, a selective antagonist at the glycine site of the NMDA receptor, counteracts haloperidol-induced muscle rigidity in rats, PSYCHOPHAR, 143(3), 1999, pp. 235-243
Chronic haloperidol and clozapine administration increases the number of cortical NMDA receptors in rats
Authors: Ossowska, K Pietraszek, M Wardas, J Nowak, G Wolfarth, S
Citation: K. Ossowska et al., Chronic haloperidol and clozapine administration increases the number of cortical NMDA receptors in rats, N-S ARCH PH, 359(4), 1999, pp. 280-287
Efficacy of pramipexole, a new dopamine receptor agonist, to relieve the parkinsonian-like muscle rigidity in rats
Authors: Lorenc-Koci, E Wolfarth, S
Citation: E. Lorenc-koci et S. Wolfarth, Efficacy of pramipexole, a new dopamine receptor agonist, to relieve the parkinsonian-like muscle rigidity in rats, EUR J PHARM, 385(1), 1999, pp. 39-46
Risultati: 1-10 |